TrialTransfusion2021

COVID-19 antibody screening with SARS-CoV-2 red cell kodecytes using routine serologic diagnostic platforms.

Radhika Nagappan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.